Paper37575469
circ_0008285 Regulates Glioma Progression via the miR-384/HMGB1 Axis.
Yan M and 5 others. Int J Genomics, 2023. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. circ_0008285 Regulates Glioma Progression via the miR-384/HMGB1 Axis. Papers, record 37575469. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37575469
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32423803 | Circular RNA hsa_circ_0008285 inhibits colorectal cancer cell proliferation and migration via the miR-382-5p/PTEN axis. | Biochem Biophys Res Commun | 2020 | https://conductscience.org/library/papers/32423803 | PubMed |
| 2 | 30719499 | Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema. | Mol Ther Oncolytics | 2019 | https://conductscience.org/library/papers/30719499 | PubMed |
| 3 | 33800703 | Noncoding RNAs in Glioblastoma: Emerging Biological Concepts and Potential Therapeutic Implications. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33800703 | PubMed |
| 4 | 35988539 | Administration of Valproic Acid Improves the Survival of Patients with Glioma Treated with Postoperative Radiotherapy. | Oncol Res Treat | 2022 | https://conductscience.org/library/papers/35988539 | PubMed |
| 5 | 27262996 | Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression. | J Mol Med (Berl) | 2016 | https://conductscience.org/library/papers/27262996 | PubMed |
| 6 | 32535033 | Circular RNA-hsa-circ-0000670 promotes gastric cancer progression through the microRNA-384/SIX4 axis. | Exp Cell Res | 2020 | https://conductscience.org/library/papers/32535033 | PubMed |
| 7 | 32196610 | LncRNA MALAT1 knockdown inhibits cell migration and invasion by suppressing autophagy through miR-384/GOLM1 axis in glioma. | Eur Rev Med Pharmacol Sci | 2020 | https://conductscience.org/library/papers/32196610 | PubMed |
| 8 | 33561315 | Circular RNA circHECTD1 facilitates glioma progression by regulating the miR-296-3p/SLC10A7 axis. | J Cell Physiol | 2021 | https://conductscience.org/library/papers/33561315 | PubMed |
| 9 | 34537217 | circRNA-miRNA-mRNA in breast cancer. | Clin Chim Acta | 2021 | https://conductscience.org/library/papers/34537217 | PubMed |
| 10 | 27310651 | Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis. | JAMA Oncol | 2016 | https://conductscience.org/library/papers/27310651 | PubMed |
| 11 | 35031058 | EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3. | Mol Cancer | 2022 | https://conductscience.org/library/papers/35031058 | PubMed |
| 12 | 33413401 | CircRNA PIP5K1A promotes the progression of glioma through upregulation of the TCF12/PI3K/AKT pathway by sponging miR-515-5p. | Cancer Cell Int | 2021 | https://conductscience.org/library/papers/33413401 | PubMed |
| 13 | 34590194 | Glioma-Targeted Therapeutics: Computer-Aided Drug Design Prospective. | Protein J | 2021 | https://conductscience.org/library/papers/34590194 | PubMed |
| 14 | 29801989 | Ten-year survival in glioblastoma. A systematic review. | J Clin Neurosci | 2018 | https://conductscience.org/library/papers/29801989 | PubMed |
| 15 | 27058823 | CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis. | Mol Ther | 2016 | https://conductscience.org/library/papers/27058823 | PubMed |
| 16 | 33962750 | Novel facets of glioma invasion. | Int Rev Cell Mol Biol | 2021 | https://conductscience.org/library/papers/33962750 | PubMed |
| 17 | 28427971 | Extent of Resection in Glioma-A Review of the Cutting Edge. | World Neurosurg | 2017 | https://conductscience.org/library/papers/28427971 | PubMed |
| 18 | 31241346 | Overexpression of high mobility group box 1 (HMGB1) has no correlation with the prognosis in glioma. | Biomark Med | 2019 | https://conductscience.org/library/papers/31241346 | PubMed |
| 19 | 33816529 | Diagnostic and Prognostic Value of Circulating CircRNAs in Cancer. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/33816529 | PubMed |
| 20 | 32122355 | Role of non-coding RNAs and RNA modifiers in cancer therapy resistance. | Mol Cancer | 2020 | https://conductscience.org/library/papers/32122355 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41284124 | CircFAT1(e2) acts as a sponge for miR-30e-5p and inhibits glioma progression by regulating MYBL2-mediated cell proliferation. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41284124 | PubMed |
| 40418306 | Circ_0008285 regulates macrophage polarization through miR-375/MAPK14 axis in sepsis-induced acute lung injury. | J Mol Histol | 2025 | https://conductscience.org/library/papers/40418306 | PubMed |
| 40148685 | Emerging role and clinical applications of circular RNAs in human diseases. | Funct Integr Genomics | 2025 | https://conductscience.org/library/papers/40148685 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37575469
GET https://conductscience.org/api/papers/v1/37575469/references?page=2